Mumbai (Maharashtra) [India], March 7 (ANI/PRNewswire): Fitterfly, a leading Indian health-tech company, working in the area of diabetes & metabolic health, recently showcased data from its Digital Therapeutics Technology platform at the 16th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2023) in Berlin, Germany. Fitterfly is the one of the few Indian healthcare companies to have received this opportunity in the last 16 years, thereby putting the company's efforts in the area of DTx on the world map. Besides research studies, this year Fitterfly was the only Indian Digital Therapeutics company invited to exhibit at the Tech Fair Expo in the innovation segment. The purpose of the ATTD meeting is to highlight innovative technologies and treatments in diabetes management. It brings together developers of new technologies with diabetes professionals and caretakers, researchers, industries, startup companies, investors, reimbursement authorities
Fitterfly presents outcomes from Digital Therapeutics Platform at 16th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2023), Germany - PRN India News webindia123.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webindia123.com Daily Mail and Mail on Sunday newspapers.